ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global IL-17 Monoclonal Antibody Injections Market Research Report 2026
Published Date: 2026-03-20
|
Report Code: QYRE-Auto-38B17303
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global IL 17 Monoclonal Antibody Injections Market Research Report 2024
BUY CHAPTERS

Global IL-17 Monoclonal Antibody Injections Market Research Report 2026

Code: QYRE-Auto-38B17303
Report
2026-03-20
Pages:103
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Novartis
UCB
Eli Lilly and Co
Astrazeneca plc

IL-17 Monoclonal Antibody Injections Market

The global IL-17 Monoclonal Antibody Injections market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on IL-17 Monoclonal Antibody Injections competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
IL-17 monoclonal antibody injection refers to a monoclonal antibody drug developed by biotechnology that targets interleukin-17 (IL-17) and is used to treat certain autoimmune diseases such as psoriasis and rheumatoid arthritis. These drugs reduce inflammatory responses by inhibiting the action of IL-17.
The North American market for IL-17 Monoclonal Antibody Injections is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for IL-17 Monoclonal Antibody Injections is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of IL-17 Monoclonal Antibody Injections include Novartis, UCB, Eli Lilly and Co., AstraZeneca, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global IL-17 Monoclonal Antibody Injections market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding IL-17 Monoclonal Antibody Injections. The IL-17 Monoclonal Antibody Injections market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global IL-17 Monoclonal Antibody Injections market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist IL-17 Monoclonal Antibody Injections manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of IL-17 Monoclonal Antibody Injections Market Report

Report Metric Details
Report Name IL-17 Monoclonal Antibody Injections Market
Segment by Type
  • Human Origin
  • Rat Origin
  • Other
by Application
  • Hospital
  • Clinic
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Novartis, UCB, Eli Lilly and Co., AstraZeneca
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for IL-17 Monoclonal Antibody Injections manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines IL-17 Monoclonal Antibody Injections sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the IL-17 Monoclonal Antibody Injections Market report?

Ans: The main players in the IL-17 Monoclonal Antibody Injections Market are Novartis, UCB, Eli Lilly and Co., AstraZeneca

What are the Application segmentation covered in the IL-17 Monoclonal Antibody Injections Market report?

Ans: The Applications covered in the IL-17 Monoclonal Antibody Injections Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the IL-17 Monoclonal Antibody Injections Market report?

Ans: The Types covered in the IL-17 Monoclonal Antibody Injections Market report are Human Origin, Rat Origin, Other

1 IL-17 Monoclonal Antibody Injections Market Overview
1.1 Product Definition
1.2 IL-17 Monoclonal Antibody Injections by Type
1.2.1 Global IL-17 Monoclonal Antibody Injections Market Value by Type: 2025 vs 2032
1.2.2 Human Origin
1.2.3 Rat Origin
1.2.4 Other
1.3 IL-17 Monoclonal Antibody Injections by Application
1.3.1 Global IL-17 Monoclonal Antibody Injections Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global IL-17 Monoclonal Antibody Injections Market Size Estimates and Forecasts
1.4.1 Global IL-17 Monoclonal Antibody Injections Revenue 2021–2032
1.4.2 Global IL-17 Monoclonal Antibody Injections Sales 2021–2032
1.4.3 Global IL-17 Monoclonal Antibody Injections Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 IL-17 Monoclonal Antibody Injections Market Competition by Manufacturers
2.1 Global IL-17 Monoclonal Antibody Injections Sales Market Share by Manufacturers (2021–2026)
2.2 Global IL-17 Monoclonal Antibody Injections Revenue Market Share by Manufacturers (2021–2026)
2.3 Global IL-17 Monoclonal Antibody Injections Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of IL-17 Monoclonal Antibody Injections, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of IL-17 Monoclonal Antibody Injections, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of IL-17 Monoclonal Antibody Injections, Product Types and Applications
2.7 Global Key Manufacturers of IL-17 Monoclonal Antibody Injections, Date of Entry into the Industry
2.8 Global IL-17 Monoclonal Antibody Injections Market Competitive Situation and Trends
2.8.1 Global IL-17 Monoclonal Antibody Injections Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global IL-17 Monoclonal Antibody Injections Players Market Share by Revenue
2.8.3 Global IL-17 Monoclonal Antibody Injections Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global IL-17 Monoclonal Antibody Injections Market Scenario by Region
3.1 Global IL-17 Monoclonal Antibody Injections Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global IL-17 Monoclonal Antibody Injections Sales by Region: 2021–2032
3.2.1 Global IL-17 Monoclonal Antibody Injections Sales by Region: 2021–2026
3.2.2 Global IL-17 Monoclonal Antibody Injections Sales by Region: 2027–2032
3.3 Global IL-17 Monoclonal Antibody Injections Revenue by Region: 2021–2032
3.3.1 Global IL-17 Monoclonal Antibody Injections Revenue by Region: 2021–2026
3.3.2 Global IL-17 Monoclonal Antibody Injections Revenue by Region: 2027–2032
3.4 North America IL-17 Monoclonal Antibody Injections Market Facts & Figures by Country
3.4.1 North America IL-17 Monoclonal Antibody Injections Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America IL-17 Monoclonal Antibody Injections Sales by Country (2021–2032)
3.4.3 North America IL-17 Monoclonal Antibody Injections Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe IL-17 Monoclonal Antibody Injections Market Facts & Figures by Country
3.5.1 Europe IL-17 Monoclonal Antibody Injections Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe IL-17 Monoclonal Antibody Injections Sales by Country (2021–2032)
3.5.3 Europe IL-17 Monoclonal Antibody Injections Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific IL-17 Monoclonal Antibody Injections Market Facts & Figures by Region
3.6.1 Asia Pacific IL-17 Monoclonal Antibody Injections Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific IL-17 Monoclonal Antibody Injections Sales by Region (2021–2032)
3.6.3 Asia Pacific IL-17 Monoclonal Antibody Injections Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America IL-17 Monoclonal Antibody Injections Market Facts & Figures by Country
3.7.1 Latin America IL-17 Monoclonal Antibody Injections Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America IL-17 Monoclonal Antibody Injections Sales by Country (2021–2032)
3.7.3 Latin America IL-17 Monoclonal Antibody Injections Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa IL-17 Monoclonal Antibody Injections Market Facts & Figures by Country
3.8.1 Middle East and Africa IL-17 Monoclonal Antibody Injections Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa IL-17 Monoclonal Antibody Injections Sales by Country (2021–2032)
3.8.3 Middle East and Africa IL-17 Monoclonal Antibody Injections Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global IL-17 Monoclonal Antibody Injections Sales by Type (2021–2032)
4.1.1 Global IL-17 Monoclonal Antibody Injections Sales by Type (2021–2026)
4.1.2 Global IL-17 Monoclonal Antibody Injections Sales by Type (2027–2032)
4.1.3 Global IL-17 Monoclonal Antibody Injections Sales Market Share by Type (2021–2032)
4.2 Global IL-17 Monoclonal Antibody Injections Revenue by Type (2021–2032)
4.2.1 Global IL-17 Monoclonal Antibody Injections Revenue by Type (2021–2026)
4.2.2 Global IL-17 Monoclonal Antibody Injections Revenue by Type (2027–2032)
4.2.3 Global IL-17 Monoclonal Antibody Injections Revenue Market Share by Type (2021–2032)
4.3 Global IL-17 Monoclonal Antibody Injections Price by Type (2021–2032)
5 Segment by Application
5.1 Global IL-17 Monoclonal Antibody Injections Sales by Application (2021–2032)
5.1.1 Global IL-17 Monoclonal Antibody Injections Sales by Application (2021–2026)
5.1.2 Global IL-17 Monoclonal Antibody Injections Sales by Application (2027–2032)
5.1.3 Global IL-17 Monoclonal Antibody Injections Sales Market Share by Application (2021–2032)
5.2 Global IL-17 Monoclonal Antibody Injections Revenue by Application (2021–2032)
5.2.1 Global IL-17 Monoclonal Antibody Injections Revenue by Application (2021–2026)
5.2.2 Global IL-17 Monoclonal Antibody Injections Revenue by Application (2027–2032)
5.2.3 Global IL-17 Monoclonal Antibody Injections Revenue Market Share by Application (2021–2032)
5.3 Global IL-17 Monoclonal Antibody Injections Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Company Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis IL-17 Monoclonal Antibody Injections Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Novartis IL-17 Monoclonal Antibody Injections Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 UCB
6.2.1 UCB Company Information
6.2.2 UCB Description and Business Overview
6.2.3 UCB IL-17 Monoclonal Antibody Injections Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 UCB IL-17 Monoclonal Antibody Injections Product Portfolio
6.2.5 UCB Recent Developments/Updates
6.3 Eli Lilly and Co.
6.3.1 Eli Lilly and Co. Company Information
6.3.2 Eli Lilly and Co. Description and Business Overview
6.3.3 Eli Lilly and Co. IL-17 Monoclonal Antibody Injections Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Eli Lilly and Co. IL-17 Monoclonal Antibody Injections Product Portfolio
6.3.5 Eli Lilly and Co. Recent Developments/Updates
6.4 AstraZeneca
6.4.1 AstraZeneca Company Information
6.4.2 AstraZeneca Description and Business Overview
6.4.3 AstraZeneca IL-17 Monoclonal Antibody Injections Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 AstraZeneca IL-17 Monoclonal Antibody Injections Product Portfolio
6.4.5 AstraZeneca Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 IL-17 Monoclonal Antibody Injections Industry Chain Analysis
7.2 IL-17 Monoclonal Antibody Injections Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 IL-17 Monoclonal Antibody Injections Production Mode & Process Analysis
7.4 IL-17 Monoclonal Antibody Injections Sales and Marketing
7.4.1 IL-17 Monoclonal Antibody Injections Sales Channels
7.4.2 IL-17 Monoclonal Antibody Injections Distributors
7.5 IL-17 Monoclonal Antibody Injections Customer Analysis
8 IL-17 Monoclonal Antibody Injections Market Dynamics
8.1 IL-17 Monoclonal Antibody Injections Industry Trends
8.2 IL-17 Monoclonal Antibody Injections Market Drivers
8.3 IL-17 Monoclonal Antibody Injections Market Challenges
8.4 IL-17 Monoclonal Antibody Injections Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Novartis
UCB
Eli Lilly and Co
Astrazeneca plc
List of Tables
 Table 1. Global IL-17 Monoclonal Antibody Injections Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global IL-17 Monoclonal Antibody Injections Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global IL-17 Monoclonal Antibody Injections Market Competitive Situation by Manufacturers in 2025
 Table 4. Global IL-17 Monoclonal Antibody Injections Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global IL-17 Monoclonal Antibody Injections Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global IL-17 Monoclonal Antibody Injections Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global IL-17 Monoclonal Antibody Injections Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market IL-17 Monoclonal Antibody Injections Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of IL-17 Monoclonal Antibody Injections, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of IL-17 Monoclonal Antibody Injections, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of IL-17 Monoclonal Antibody Injections, Product Types and Applications
 Table 12. Global Key Manufacturers of IL-17 Monoclonal Antibody Injections, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global IL-17 Monoclonal Antibody Injections Companies by Tier (Tier 1, Tier 2, Tier 3), based on IL-17 Monoclonal Antibody Injections Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global IL-17 Monoclonal Antibody Injections Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global IL-17 Monoclonal Antibody Injections Sales by Region (K Units), 2021–2026
 Table 18. Global IL-17 Monoclonal Antibody Injections Sales Market Share by Region (2021–2026)
 Table 19. Global IL-17 Monoclonal Antibody Injections Sales by Region (K Units), 2027–2032
 Table 20. Global IL-17 Monoclonal Antibody Injections Sales Market Share by Region (2027–2032)
 Table 21. Global IL-17 Monoclonal Antibody Injections Revenue by Region (US$ Million), 2021–2026
 Table 22. Global IL-17 Monoclonal Antibody Injections Revenue Market Share by Region (2021–2026)
 Table 23. Global IL-17 Monoclonal Antibody Injections Revenue by Region (US$ Million), 2027–2032
 Table 24. Global IL-17 Monoclonal Antibody Injections Revenue Market Share by Region (2027–2032)
 Table 25. North America IL-17 Monoclonal Antibody Injections Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America IL-17 Monoclonal Antibody Injections Sales by Country (K Units), 2021–2026
 Table 27. North America IL-17 Monoclonal Antibody Injections Sales by Country (K Units), 2027–2032
 Table 28. North America IL-17 Monoclonal Antibody Injections Revenue by Country (US$ Million), 2021–2026
 Table 29. North America IL-17 Monoclonal Antibody Injections Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe IL-17 Monoclonal Antibody Injections Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe IL-17 Monoclonal Antibody Injections Sales by Country (K Units), 2021–2026
 Table 32. Europe IL-17 Monoclonal Antibody Injections Sales by Country (K Units), 2027–2032
 Table 33. Europe IL-17 Monoclonal Antibody Injections Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe IL-17 Monoclonal Antibody Injections Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific IL-17 Monoclonal Antibody Injections Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific IL-17 Monoclonal Antibody Injections Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific IL-17 Monoclonal Antibody Injections Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific IL-17 Monoclonal Antibody Injections Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific IL-17 Monoclonal Antibody Injections Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America IL-17 Monoclonal Antibody Injections Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America IL-17 Monoclonal Antibody Injections Sales by Country (K Units), 2021–2026
 Table 42. Latin America IL-17 Monoclonal Antibody Injections Sales by Country (K Units), 2027–2032
 Table 43. Latin America IL-17 Monoclonal Antibody Injections Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America IL-17 Monoclonal Antibody Injections Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa IL-17 Monoclonal Antibody Injections Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa IL-17 Monoclonal Antibody Injections Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa IL-17 Monoclonal Antibody Injections Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa IL-17 Monoclonal Antibody Injections Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa IL-17 Monoclonal Antibody Injections Revenue by Country (US$ Million), 2027–2032
 Table 50. Global IL-17 Monoclonal Antibody Injections Sales (K Units) by Type (2021–2026)
 Table 51. Global IL-17 Monoclonal Antibody Injections Sales (K Units) by Type (2027–2032)
 Table 52. Global IL-17 Monoclonal Antibody Injections Sales Market Share by Type (2021–2026)
 Table 53. Global IL-17 Monoclonal Antibody Injections Sales Market Share by Type (2027–2032)
 Table 54. Global IL-17 Monoclonal Antibody Injections Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global IL-17 Monoclonal Antibody Injections Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global IL-17 Monoclonal Antibody Injections Revenue Market Share by Type (2021–2026)
 Table 57. Global IL-17 Monoclonal Antibody Injections Revenue Market Share by Type (2027–2032)
 Table 58. Global IL-17 Monoclonal Antibody Injections Price (US$/Unit) by Type (2021–2026)
 Table 59. Global IL-17 Monoclonal Antibody Injections Price (US$/Unit) by Type (2027–2032)
 Table 60. Global IL-17 Monoclonal Antibody Injections Sales (K Units) by Application (2021–2026)
 Table 61. Global IL-17 Monoclonal Antibody Injections Sales (K Units) by Application (2027–2032)
 Table 62. Global IL-17 Monoclonal Antibody Injections Sales Market Share by Application (2021–2026)
 Table 63. Global IL-17 Monoclonal Antibody Injections Sales Market Share by Application (2027–2032)
 Table 64. Global IL-17 Monoclonal Antibody Injections Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global IL-17 Monoclonal Antibody Injections Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global IL-17 Monoclonal Antibody Injections Revenue Market Share by Application (2021–2026)
 Table 67. Global IL-17 Monoclonal Antibody Injections Revenue Market Share by Application (2027–2032)
 Table 68. Global IL-17 Monoclonal Antibody Injections Price (US$/Unit) by Application (2021–2026)
 Table 69. Global IL-17 Monoclonal Antibody Injections Price (US$/Unit) by Application (2027–2032)
 Table 70. Novartis Company Information
 Table 71. Novartis Description and Business Overview
 Table 72. Novartis IL-17 Monoclonal Antibody Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. Novartis IL-17 Monoclonal Antibody Injections Product
 Table 74. Novartis Recent Developments/Updates
 Table 75. UCB Company Information
 Table 76. UCB Description and Business Overview
 Table 77. UCB IL-17 Monoclonal Antibody Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. UCB IL-17 Monoclonal Antibody Injections Product
 Table 79. UCB Recent Developments/Updates
 Table 80. Eli Lilly and Co. Company Information
 Table 81. Eli Lilly and Co. Description and Business Overview
 Table 82. Eli Lilly and Co. IL-17 Monoclonal Antibody Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. Eli Lilly and Co. IL-17 Monoclonal Antibody Injections Product
 Table 84. Eli Lilly and Co. Recent Developments/Updates
 Table 85. AstraZeneca Company Information
 Table 86. AstraZeneca Description and Business Overview
 Table 87. AstraZeneca IL-17 Monoclonal Antibody Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. AstraZeneca IL-17 Monoclonal Antibody Injections Product
 Table 89. AstraZeneca Recent Developments/Updates
 Table 90. Key Raw Materials Lists
 Table 91. Raw Materials Key Suppliers Lists
 Table 92. IL-17 Monoclonal Antibody Injections Distributors List
 Table 93. IL-17 Monoclonal Antibody Injections Customers List
 Table 94. IL-17 Monoclonal Antibody Injections Market Trends
 Table 95. IL-17 Monoclonal Antibody Injections Market Drivers
 Table 96. IL-17 Monoclonal Antibody Injections Market Challenges
 Table 97. IL-17 Monoclonal Antibody Injections Market Restraints
 Table 98. Research Programs/Design for This Report
 Table 99. Key Data Information from Secondary Sources
 Table 100. Key Data Information from Primary Sources
 Table 101. Authors List of This Report


List of Figures
 Figure 1. Product Picture of IL-17 Monoclonal Antibody Injections
 Figure 2. Global IL-17 Monoclonal Antibody Injections Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global IL-17 Monoclonal Antibody Injections Market Share by Type: 2025 & 2032
 Figure 4. Human Origin Product Picture
 Figure 5. Rat Origin Product Picture
 Figure 6. Other Product Picture
 Figure 7. Global IL-17 Monoclonal Antibody Injections Market Value by Application (US$ Million), 2021–2032
 Figure 8. Global IL-17 Monoclonal Antibody Injections Market Share by Application: 2025 & 2032
 Figure 9. Hospital
 Figure 10. Clinic
 Figure 11. Other
 Figure 12. Global IL-17 Monoclonal Antibody Injections Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 13. Global IL-17 Monoclonal Antibody Injections Market Size (US$ Million), 2021–2032
 Figure 14. Global IL-17 Monoclonal Antibody Injections Sales (K Units), 2021–2032
 Figure 15. Global IL-17 Monoclonal Antibody Injections Average Price (US$/Unit), 2021–2032
 Figure 16. IL-17 Monoclonal Antibody Injections Report Years Considered
 Figure 17. IL-17 Monoclonal Antibody Injections Sales Share by Manufacturers in 2025
 Figure 18. Global IL-17 Monoclonal Antibody Injections Revenue Share by Manufacturers in 2025
 Figure 19. Top 5 and Top 10 Global IL-17 Monoclonal Antibody Injections Players: Market Share by Revenue in IL-17 Monoclonal Antibody Injections in 2025
 Figure 20. IL-17 Monoclonal Antibody Injections Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 21. Global IL-17 Monoclonal Antibody Injections Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 22. North America IL-17 Monoclonal Antibody Injections Sales Market Share by Country (2021–2032)
 Figure 23. North America IL-17 Monoclonal Antibody Injections Revenue Market Share by Country (2021–2032)
 Figure 24. United States IL-17 Monoclonal Antibody Injections Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Canada IL-17 Monoclonal Antibody Injections Revenue Growth Rate (US$ Million), 2021–2032
 Figure 26. Europe IL-17 Monoclonal Antibody Injections Sales Market Share by Country (2021–2032)
 Figure 27. Europe IL-17 Monoclonal Antibody Injections Revenue Market Share by Country (2021–2032)
 Figure 28. Germany IL-17 Monoclonal Antibody Injections Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. France IL-17 Monoclonal Antibody Injections Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. U.K. IL-17 Monoclonal Antibody Injections Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Italy IL-17 Monoclonal Antibody Injections Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Russia IL-17 Monoclonal Antibody Injections Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Asia Pacific IL-17 Monoclonal Antibody Injections Sales Market Share by Region (2021–2032)
 Figure 34. Asia Pacific IL-17 Monoclonal Antibody Injections Revenue Market Share by Region (2021–2032)
 Figure 35. China IL-17 Monoclonal Antibody Injections Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Japan IL-17 Monoclonal Antibody Injections Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. South Korea IL-17 Monoclonal Antibody Injections Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. India IL-17 Monoclonal Antibody Injections Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Australia IL-17 Monoclonal Antibody Injections Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. China Taiwan IL-17 Monoclonal Antibody Injections Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Southeast Asia IL-17 Monoclonal Antibody Injections Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Latin America IL-17 Monoclonal Antibody Injections Sales Market Share by Country (2021–2032)
 Figure 43. Latin America IL-17 Monoclonal Antibody Injections Revenue Market Share by Country (2021–2032)
 Figure 44. Mexico IL-17 Monoclonal Antibody Injections Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Brazil IL-17 Monoclonal Antibody Injections Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Argentina IL-17 Monoclonal Antibody Injections Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Colombia IL-17 Monoclonal Antibody Injections Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Middle East and Africa IL-17 Monoclonal Antibody Injections Sales Market Share by Country (2021–2032)
 Figure 49. Middle East and Africa IL-17 Monoclonal Antibody Injections Revenue Market Share by Country (2021–2032)
 Figure 50. Turkey IL-17 Monoclonal Antibody Injections Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Saudi Arabia IL-17 Monoclonal Antibody Injections Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. UAE IL-17 Monoclonal Antibody Injections Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Global Sales Market Share of IL-17 Monoclonal Antibody Injections by Type (2021–2032)
 Figure 54. Global Revenue Market Share of IL-17 Monoclonal Antibody Injections by Type (2021–2032)
 Figure 55. Global IL-17 Monoclonal Antibody Injections Price (US$/Unit) by Type (2021–2032)
 Figure 56. Global Sales Market Share of IL-17 Monoclonal Antibody Injections by Application (2021–2032)
 Figure 57. Global Revenue Market Share of IL-17 Monoclonal Antibody Injections by Application (2021–2032)
 Figure 58. Global IL-17 Monoclonal Antibody Injections Price (US$/Unit) by Application (2021–2032)
 Figure 59. IL-17 Monoclonal Antibody Injections Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Global IL 17 Targeting Biological Drugs Market Research Report 2024
Global Interleukin 17 Inhibitors Market Research Report 2024
Global IL 17 Inhibitors for Psoriasis Market Research Report 2024
Global Arthritis Monoclonal Antibodies Market Research Report 2024
Global Secukinumab Market Research Report 2024
Global Monoclonal Antibodies for Plaque Psoriasis Market Research Report 2024
Global Infliximab Injection Market Research Report 2024
Global Anti TNF α Monoclonal Antibody Market Insights Forecast to 2030
Rituximab Injection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Monoclonal Antibodies for Alzheimer Disease Market Research Report 2024
Global Interleukin Inhibitors for Psoriasis Market Research Report 2024
Global Interleukin 17A IL 17A ELISA Kit Market Research Report 2024
Global Ustekinumab Biosimilars Market Research Report 2024
Global Rituximab Biosimilars Market Research Report 2025
Monoclonal Antibody Biologics and Biosimilars Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Recombinant Rituximab Injection Market Research Report 2024
Global Therapeutic Monoclonal Antibodies Market Research Report 2024
Global Therapeutic Monoclonal Antibodies Drug Market Research Report 2024
Global Aβ Monoclonal Antibody Drug Market Research Report 2024
Global Emicizumab Injection Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions